nti–IL-5 Therapies Can Be Life-Changing for Patients With Eosinophilic Asthma

Categorizing patients into eosinophilic and noneosinophilic subtypes enables better targeted treatment, emphasized Anne Reihman, MD, third-year pulmonary and critical care fellow, University of Colorado, Division of Pulmonary Sciences and Critical Care Medicine.